Get the Stockscreener App
2.055
6.01%
-0.105
Immunoprecise Antibodies Ltd stock is traded at $2.055, with a volume of 958.18K.
It is down -6.01% in the last 24 hours and up +82.89% over the past month.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
See More
Previous Close:
$2.16
Open:
$2.22
24h Volume:
958.18K
Relative Volume:
0.43
Market Cap:
$88.92M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-4.3336
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
+16.01%
1M Performance:
+82.89%
6M Performance:
+289.65%
1Y Performance:
+136.06%
1-Day Range:
$2.0201
$2.29
1-Week Range:
$1.61
$2.41
52-Week Range:
$0.30
$2.41
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Name
Immunoprecise Antibodies Ltd
Sector
Industry
Phone
-
Address
-
Compare IPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
2.04 | 98.85M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.67 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.24 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.31 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
597.35 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.96 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Stock (IPA) Latest News
What does recent volatility data suggest for ImmunoPrecise Antibodies Ltd.Free Real-Time Analysis With Entry Targets - Newser
What are analysts’ price targets for ImmunoPrecise Antibodies Ltd. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
Is ImmunoPrecise Antibodies Ltd. a growth stock or a value stockMaximize returns with expert trading insights - jammulinksnews.com
What is ImmunoPrecise Antibodies Ltd. company’s growth strategyStay informed with expert market forecasts - jammulinksnews.com
Is it the right time to buy ImmunoPrecise Antibodies Ltd. stockGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What are the technical indicators suggesting about ImmunoPrecise Antibodies Ltd.Breakthrough financial growth - jammulinksnews.com
Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionSecure Growth Trading Plan - Newser
How ImmunoPrecise Antibodies Ltd. stock performs during market volatilitySmart Money Signals - Newser
Is ImmunoPrecise Antibodies Ltd. stock a good hedge against inflationLow Volatility High Yield Stocks - Newser
How Efficient Is ImmunoPrecise Antibodies Ltd. at Controlling Operating CostsOptimized Return Investment Picks - Newser
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyUnlock powerful portfolio optimization tools - jammulinksnews.com
ImmunoPrecise Antibodies Ltd. Stock Support and Resistance Levels You Should KnowSafe and Smart Investment Picks - Newser
IPA Expands Study on LENSai Immunogenicity Screening: A Game-Changer for Biologics Development - AInvest
Is ImmunoPrecise Antibodies Ltd. a good long term investmentMarket-leading profit generation - PrintWeekIndia
IPA’s Stock Market Labyrinth: Navigating 2025’s Gains and Declines - investchronicle.com
Insight Molecular Diagnostics Inc. shares fall 3.16% intraday as ImmunoPrecise Antibodies Ltd. announces new findings. - AInvest
ImmunoPrecise Unveils Breakthrough in Predicting Drug Antibody Risks - TipRanks
ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic - Yahoo Finance
What drives ImmunoPrecise Antibodies Ltd. stock priceDynamic portfolio growth - Autocar Professional
What analysts say about ImmunoPrecise Antibodies Ltd. stockFree Predictions - jammulinksnews.com
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
ImmunoPrecise Strengthens Advisory Board with AI Expert Jeff Fried - The Globe and Mail
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Stock Price Down 0.6% – What’s Next? - Defense World
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board - 01net
ImmunoPrecise Antibodies appoints data expert Jeff Fried to advisory board - Investing.com Australia
ImmunoPrecise Antibodies appoints data expert Jeff Fried to advisory board By Investing.com - Investing.com India
why immunoprecise antibodies ltd. stock attracts strong analyst attentionMarket Beating Strategy - Newser
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025 - 01net
ImmunoPrecise Antibodies to Announce Q4 and FY 2025 Results - TipRanks
Tech Momentum Surges as IPA, HIT, SNYR, PNPN.V, KAPA and Others Drive Investor Awareness – More Stocks Inside - FinancialContent
Immunoprecise Antibodies Ltd Stock (IPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):